Center Podiatry in Higganum, CT - Podiatrist

Center Podiatry is a Podiatrist based in Higganum, Connecticut. Center Podiatry is licensed to practice in * (Not Available) (license number ) and their current practice location is 415 Killingworth Rd, Higganum, Connecticut. It can be reached at their office (for appointments etc.) via phone at (203) 799-3668.

NPI number for Center Podiatry is 1720348881 and their current mailing address is 109 Boston Post Rd, Orange, Connecticut. Center Podiatry does not participate in medicare program and thus does not accept medicare assignments. The facility's NPI Number is 1720348881.

Contact Information

	Center Podiatry
	415 Killingworth Rd, Higganum, CT 06441-4370
	(203) 799-3668
	(203) 891-0766

Healthcare Provider's Profile

Full Name	Center Podiatry
Type	Facility
Speciality	Podiatrist
Location	415 Killingworth Rd, Higganum, Connecticut
Accepts Medicare Assignments	Does not participate in Medicare Program. The facility may not accept medicare assignment.

NPI Data:

NPI Number: 1720348881
Provider Enumeration Date: 05/23/2012
Last Update Date: 05/29/2012

Medical Identifiers

Medical identifiers for Center Podiatry such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1720348881	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
213E00000X	Podiatrist	(* (Not Available))	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Center Podiatry is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Center Podiatry 109 Boston Post Rd, Orange, CT 06477-3235 Ph: (203) 799-3668	Center Podiatry 415 Killingworth Rd, Higganum, CT 06441-4370 Ph: (203) 799-3668

News Archive

Cell Biosciences receives US Patent for NanoPro assay technology

Cell Biosciences, Inc. today announced the issuance of Patent No. 7,846,676 for "Methods and Devices for Analyte Detection" by the United States Patent and Trademark Office.

Clot-busting medications for treating pulmonary embolism patients linked with fewer deaths

Bringing clarity to a decades-long debate, a national team of researchers led by experts from the Perelman School of Medicine at the University of Pennsylvania has found that adding clot-busting medications known as thrombolytics to conventional approaches when treating sudden-onset pulmonary embolism patients is associated with 47 percent fewer deaths than using standard intravenous or under-the-skin anticoagulant medications alone.

Cardinal Health patents disposable Nitrile gloves

Tillotson Corp. today announced that Cardinal Health has licensed a Tillotson U.S. patent for disposable Nitrile Gloves.

Study finds long-term outcomes of weight loss surgery in children, adolescents with severe obesity

Results from a 10-year study of children and adolescents who underwent a common weight loss operation to treat severe obesity show they safely have long-lasting major weight loss and improvement of their obesity-related medical problems without stunting their growth in height. The study, involving the longest known follow-up of pediatric patients after laparoscopic sleeve gastrectomy, is published online by the Journal of the American College of Surgeons ahead of print.

Center Podiatry - Podiatrist in Higganum, CT